Switch to:

Sangamo Therapeutics Other Income (Expense)

: $-0.0 Mil (TTM As of Jun. 2020)
View and export this data going back to 2000. Start your Free Trial

Sangamo Therapeutics's other income expense for the Sangamo Therapeutics's pretax income for the three months ended in Jun. 2020 was $-0.0 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2020 was $-0.0 Mil.


Sangamo Therapeutics Other Income (Expense) Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Sangamo Therapeutics Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Other Income (Expense) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sangamo Therapeutics Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Other Income (Expense) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 -0.00

Sangamo Therapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2020 was 0 (Sep. 2019 ) + 2.2204460492503E-16 (Dec. 2019 ) + 0 (Mar. 2020 ) + -7.105427357601E-15 (Jun. 2020 ) = $-0.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Sangamo Therapeutics  (NAS:SGMO) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Sangamo Therapeutics Other Income (Expense) Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)